Stock·NYSE·Consumer Defensive
Constellation Brands Inc. Class A (STZ)
- Market cap
- $21.93B
- P/E
- 11.57
- Dividend yield
- 3.13%
- Street target
- $150.00median of 24 analysts
- 52-week range
- $110.60 $168.60
The short version
Where STZ stands today, in four lines, and what CleaRank Financial AI makes of it.
STZ at a glance
Constellation Brands Inc. Class A (STZ): Hold, 58/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($125.53 and $142.46).
- Earnings STZ beat estimates in 5 of its last 6 quarters, and the stock rose the next day every time.
- Insiders Insiders sold $1.8M and bought $341K over the last 18 months.
- Valuation P/E of 11.6 against 24.2 for the Consumer Defensive sector: a discount to peers (-52%).
Figures as of October 16, 2026.
CleaRank Financial AI
Constellation Brands Inc. (STZ) is currently trading at $131.07, just above its 50-day SMA of $125.53 but below its 200-day SMA of $142.46.
The stock exhibits overbought momentum with a 14-day RSI of 70.5, suggesting a potential for a short-term pullback. Despite this, the company has a history of beating earnings estimates, with its most recent report on October 6, 2026, showing an EPS beat of 5.35% and a 2.35% stock price increase. The company operates in the Beverages - Brewers industry within the Consumer Defensive sector. Its fundamentals show a strong return on equity of 24.01% and a healthy profit margin of 20.90%, though its revenue growth of 6.1% is slightly above the sector median of 5.3%. However, recent revenue estimates indicate a slight contraction for the current and next quarters. Insiders are net sellers with $1.8M in total sales versus $341K in total purchases in recent filings.
Only on CleaRank
Figures we compute ourselves from STZ's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $131.07 is 4.4% above the 50-day simple moving average of $125.53.Price above its 200-day average ›
The price is 8.0% below the 200-day simple moving average of $142.46.50-day average above the 200-day ›
The 50-day average ($125.53) is 11.9% below the 200-day average ($142.46), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 35% of its 52-week range, between $110.60 and $168.60.
STZ share price
Pick a period: each tab shows how far STZ has moved over it, to the last close.
Today's trading
Where STZ sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 11.57 is 52.2% below the Consumer Defensive median of 24.2.P/S below the sector median ›
The price-to-sales ratio of 2.38 is 8.2% above the sector median of 2.2.Profitable over the last 12 months ›
Net income over the last 12 months was $1.9B on revenue of $9.2B, a net margin of 20.9%.Beat estimates in most recent reports ›
STZ beat the EPS estimate in 5 of its last 6 reports.Pays a dividend ›
The trailing dividend yield is 3.13%, or $4.10 a share a year.
Key statistics
The headline figures for STZ.
As of October 16, 2026, STZ trades at $131.07, with a market value of $21.93B, a P/E ratio of 11.57 and a dividend yield of 3.13%.
What the numbers say
CleaRank Financial AI's reading of STZ's valuation, growth and risks.
Constellation Brands trades at a P/E ratio of 11.57, which is considerably lower than the sector average of 24.2, suggesting a potential valuation discount.
Its price-to-sales ratio of 2.38 is slightly above the sector average of 2.2, but its strong profit margin of 20.90% and return on equity of 24.01% indicate efficient operations and profitability. The company's debt-to-equity ratio of 1.16 is in line with the sector average. While revenue growth has been positive at 6.1%, forward estimates suggest a slight contraction in the coming quarters. The current valuation appears attractive relative to its profitability and sector peers, but the slowing revenue growth warrants monitoring.
STZ against the Consumer Defensive sector
How STZ compares with the median Consumer Defensive stock CleaRank tracks.
Price to earnings vs sector: STZ trades at a notable discount to sector peers (-52%), which may indicate undervaluation or specific company headwinds.
Return vs VDC: Since May 6, 2025, STZ has lost 29.9% against a gain of 7.9% for VDC.
Performance against VDC
STZ and the Consumer Defensive sector fund over the same days.
Revenue and earnings
How much STZ sells, and how much of it becomes profit.
Revenue growth: Revenue fell 10.5% in FY2026 to $9.1B, from $10.2B a year earlier.
Profit margin: The net margin was 19.2% in FY2026, up from -0.3% the year before.
Profitable: STZ earned $1.8B in FY2026.
Earnings reality check
Did STZ beat what analysts expected, and how did the stock react?
Earnings record: STZ beat the analyst estimate in 5 of the last 6 quarters.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 6, 2026after close | $3.55 | $3.74 | +5.35% | +2.35% | +9.85% |
| Apr 8, 2026after close | $1.71 | $1.90 | +11.11% | +8.53% | +9.11% |
| Jan 7, 2026after close | $2.63 | $3.06 | +16.35% | +5.32% | +11.30% |
| Oct 6, 2025after close | $3.41 | $3.63 | +6.45% | +1.03% | +1.97% |
| Jul 1, 2025after close | $3.29 | $3.22 | -2.13% | +4.48% | +1.57% |
| Apr 9, 2025after close | $2.27 | $2.63 | +15.86% | +0.74% | -0.20% |
As of October 16, 2026, STZ has beaten the analyst EPS estimate in 5 of its last 6 reported quarters and rose in the first trading session after every one of those beats; its latest report, on October 6, 2026, came in 5.35% above the estimate and the stock moved +2.35% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 70.5, in overbought territory.RSI above 50 ›
An RSI of 70.5 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of STZ
The score, the reasoning behind it, and what could move the price next.
Constellation Brands' stock is currently trading above its 50-day SMA ($125.53) and 20-day EMA ($122.64), indicating short-term positive momentum.
However, it remains below its 200-day SMA ($142.46), suggesting a longer-term downtrend or consolidation. The 14-day RSI is at 70.5, signaling an overbought condition that could precede a price correction. Key support is seen around the 50-day SMA, while resistance lies near the 200-day SMA and potentially psychological levels around $140. The stochastic indicator is also in overbought territory, reinforcing the potential for a near-term pullback.
Consistent Earnings Beats ›
Constellation Brands has a track record of exceeding analyst EPS estimates, most recently by 5.35% on October 6, 2026, which has historically supported the stock price.
Source: Company Earnings ReportsAttractive Valuation Relative to Peers ›
The company's P/E ratio of 11.57 is substantially lower than the sector average of 24.2, presenting a value opportunity for investors.
Source: Financial Data AnalysisProjected Revenue Contraction ›
Forward revenue estimates indicate a slight decline for the current and next quarters, potentially impacting top-line growth momentum.
Source: Analyst Revenue Estimates
Moderate Insider Selling ›
Insiders have sold approximately $1.8 million in stock versus purchases of $340.9 thousand, indicating a net selling position that warrants caution.
Source: Insider Transaction DataOverbought Technical Conditions ›
The 14-day RSI is at 70.5, signaling an overbought condition that historically precedes price corrections.
Source: Technical Analysis Indicators
- The stock's RSI is currently overbought at 70.5, suggesting a potential for a short-term pullback; consider waiting for a more favorable entry point.
Technical indicators
Momentum and trend for STZ, from its daily closes.
As of October 16, 2026, with STZ at $131.07, its 14-day RSI is 70.5 (overbought territory), its 50-day simple moving average is $125.53 and its 200-day is $142.46.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What STZ moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, STZ's 1-year correlation of daily returns is +0.16 with S&P 500 (SPY), +0.06 with Nasdaq 100 (QQQ), -0.09 with Bitcoin (BTC) and +0.06 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
14 of 24 analysts rate it a buy or strong buy, 8 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $150.00 is 14.4% above the price.More buy ratings than three months ago ›
14 of 24 rate it a buy now, against 14 of 24 three months ago.
STZ Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 8, 2026 | JP Morgan | Maintains | Neutral |
| Oct 8, 2026 | Freedom Broker | Upgrade | Buy |
| Oct 8, 2026 | UBS | Maintains | Buy |
| Oct 8, 2026 | Piper Sandler | Maintains | Neutral |
| Oct 8, 2026 | Deutsche Bank | Maintains | Hold |
| Oct 8, 2026 | RBC Capital | Maintains | Outperform |
As of October 16, 2026, 24 Wall Street analysts cover STZ: 14 rate it a buy or strong buy, 8 a hold and 2 a sell or strong sell. Their 12-month price targets range from $99.00 to $209.00, with a median of $150.00, 14.4% above the price of $131.07.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
STZ trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from STZ's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much STZ tends to move, against the market and on its own.
The long record
STZ's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 1.86% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 55.8%, from March 2024 to September 2026; the price is still 48.7% below that peak.Most 1-year holds ended higher ›
53% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $9,974.44, against $42,525 in the S&P 500 (SPY).
STZ Drawdowns & Recovery
As of October 16, 2026, STZ's worst peak-to-trough fall over the last 10 years with dividends reinvested was -55.8% (March 2024 to September 2026); it is still 48.7% below that peak, and 53% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into STZ in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: STZ trailed the S&P 500 over this period: $9,974.44 against $42,525.
A $10,000 investment in STZ in October 2016 would be worth about $9,974 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to STZ, and which have not.
Strongest month, April: an average of +6.27%, up in 9 of 10 years.
Weakest month, October: an average of -2.44%, up in 3 of 9 years.
This month, October: has averaged -2.44%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, STZ's strongest calendar month has been April (average +6.27%, up in 9 of 10 years) and its weakest October (average -2.44%, up in 3 of 9 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in STZ, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in STZ today could grow to about $11,810 by 2036 in the base case, with a 90th-percentile outcome near $36,041 and a 10th-percentile outcome around $3,870. The simulation models price only; at today's 3.13% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
STZ Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $140 for STZ by 2030 in the base case, from $131 today (1.1x over 4 years). The 10th-percentile path ends near $69.17. These are outcomes of a Monte Carlo simulation run on STZ's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $93.65 | $133 | $190 | |
| 2028 | $82.27 | $136 | $223 | |
| 2029 | $74.78 | $138 | $254 | |
| 2030 | $69.17 | $140 | $284 | |
| 2031 | $64.71 | $142 | $314 |
Method: a lognormal simulation of STZ's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
STZ insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $341K on the open market and sold $1.8M.
As of October 16, 2026, STZ insiders reported 5 open-market sales worth $1.8M and 1 open-market purchase worth $341K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 10, 2026 | Christopher J. Baldwin
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Christy Clark
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Jennifer M. Daniels
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Nicholas I. Fink
Chief Executive Officer
|
Grant | 1.1K | - |
| Jul 10, 2026 | Edith Morgan Flatley
Director
|
Grant | 187 | - |
| Jul 10, 2026 | William T Giles
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Ernesto M. Hernandez
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Garza Jose Manuel Madero
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Daniel J Mccarthy
Director
|
Grant | 1.1K | - |
| Jul 10, 2026 | Richard Sands
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 1.1K | - |
| Jul 10, 2026 | Robert S Sands
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 1.1K | - |
| Jul 10, 2026 | Luca Zaramella
Director
|
Grant | 1.1K | - |
| May 12, 2026 | James O Bourdeau
Officer
|
Sell | 4.4K | $631.3K |
| May 1, 2026 | James O Bourdeau
Officer
|
Grant | 6.0K | - |
| May 1, 2026 | Paula Kristine Erickson
Officer
|
Grant | 1.8K | - |
| May 1, 2026 | Samuel J Glaetzer
Officer
|
Grant | 2.8K | - |
| May 1, 2026 | Garth Hankinson
Chief Financial Officer
|
Grant | 7.5K | - |
| May 1, 2026 | Jeffrey H. Labarge
Officer
|
Grant | 1.6K | - |
| May 1, 2026 | Michael Mcgrew
Officer
|
Grant | 2.1K | - |
| May 1, 2026 | Mallika Monteiro
Officer
|
Grant | 2.9K | - |
| May 1, 2026 | James Anthony Sabia Jr.
Officer
|
Grant | 5.5K | - |
| Apr 27, 2026 | Ernesto M. Hernandez
Director
|
Sell | 2.0K | $307.8K |
| Feb 17, 2026 | Samuel J Glaetzer
Officer
|
Sell | 555 | $85.3K |
| Jul 21, 2025 | James O Bourdeau
Officer
|
Sell | 821 | $138.7K |
| Jul 10, 2025 | Christopher J. Baldwin
Chairman of the Board
|
Grant | 503 | - |
| Jul 10, 2025 | Christy Clark
Director
|
Grant | 503 | - |
| Jul 10, 2025 | Jennifer M. Daniels
Director
|
Grant | 503 | - |
| Jul 10, 2025 | Nicholas I. Fink
Director
|
Grant | 503 | - |
| Jul 10, 2025 | William T Giles
Director
|
Grant | 503 | - |
| Jul 10, 2025 | Ernesto M. Hernandez
Director
|
Grant | 503 | - |
| Jul 10, 2025 | Garza Jose Manuel Madero
Director
|
Grant | 503 | - |
| Jul 10, 2025 | Daniel J Mccarthy
Director
|
Grant | 503 | - |
| Jul 10, 2025 | Richard Sands
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 503 | - |
| Jul 10, 2025 | Robert S Sands
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 503 | - |
| Jul 10, 2025 | Luca Zaramella
Director
|
Grant | 503 | - |
| Jul 8, 2025 | Christopher J. Baldwin
Director
|
Buy | 2.0K | $340.9K |
| May 13, 2025 | Samuel J Glaetzer
Officer
|
Sell | 3.2K | $593.9K |
| May 1, 2025 | James O Bourdeau
Officer
|
Grant | 3.4K | - |
| May 1, 2025 | Samuel J Glaetzer
Officer
|
Grant | 1.9K | - |
| May 1, 2025 | Garth Hankinson
Chief Financial Officer
|
Grant | 3.5K | - |
| May 1, 2025 | Michael Mcgrew
Officer
|
Grant | 1.0K | - |
| May 1, 2025 | Mallika Monteiro
Officer
|
Grant | 2.0K | - |
| May 1, 2025 | William A Newlands
Chief Executive Officer
|
Grant | 12.8K | - |
| May 1, 2025 | James Anthony Sabia Jr.
Officer
|
Grant | 2.4K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.